Abbott Q4 earnings up 60%

Abbott Laboratories (ABT) Q4 results: Revenues: $8,314M (+7.1%); Nutrition: $1,868M (+5.2%); Diagnostics: $2,058M (+5.0%); Established Pharmaceuticals: $1,174M (+7.8%); Medical Devices: $3,204M (+9.7%).

Net Income: $1,049M (+60.4%); EPS: $0.59 (+59.5%); non-GAAP Net Income: $1,705M (+18.1%); non-GAAP EPS: $0.95 (+17.3%).

2020 Guidance: GAAP EPS: $2.35 – 2.45; Non-GAAP EPS: $3.55 – 3.65.

Q1 Guidance: GAAP EPS: $0.40 – 0.42; Non-GAAP EPS: $0.69 – 0.71.

https://seekingalpha.com/news/3533407-abbott-q4-earnings-up-60-shares-up-1-premarket